Keratoconus

Corneal Collagen Cross-Linking in Tampa & Sebring

You deserve NEWSOM EYES!

Cross-linking is the only procedure that can strengthen the cornea enough to slow or stop keratoconus from getting worse. Before it existed, there was no way to halt the disease at all.

Keratoconus treated with corneal collagen cross-linking
25+ Years
Serving Florida patients
100,000+
Surgeries performed
5 Locations
Sebring to Gainesville
3 Surgery Centers
AAAHC accredited
Corneal collagen cross-links strengthening the cornea
The Condition

What is keratoconus?

Keratoconus is an abnormality of the eye in which the normally round, dome-shaped cornea weakens and becomes progressively thinner and irregular in shape. The resulting cone-shaped cornea can cause high levels of astigmatism — irregular curvature — and nearsightedness.

Keratoconus has been estimated to occur in one out of every 1,000 people in the general population, and is generally first diagnosed in young people at puberty or in their late teens.

Prior to collagen cross-linking there was no way to stop the progression of this disease. That is what makes early diagnosis worth so much: the cornea you still have is the cornea cross-linking preserves.

  • 1 in 1,000 people in the general population.
  • Diagnosed young — typically at puberty or in the late teens.
  • Progressive until it is treated, then usually stable.
Cornea treated with UVA light and riboflavin during cross-linking
The Procedure

What is collagen cross-linking?

Corneal collagen cross-linking (CXL), a procedure first developed in Dresden, Germany in the 1990s, is used to treat individuals with progressive keratoconus. It is the only procedure that can strengthen the cornea to slow or stop the progression of the disease.

This minimally invasive treatment uses vitamin B2 (riboflavin) eye drops and ultraviolet (UVA) light to increase the cornea’s collagen connections — the cross-links — which help the cornea retain its firmness and shape.

Cross-linking is not a cure for keratoconus. It stops the cornea getting worse; it does not return it to its original shape. Vision correction afterward is usually still needed, often with specialty contact lenses.

  • Riboflavin drops saturate the cornea first.
  • UVA light activates them, forming new collagen cross-links.
  • Not a cure — it halts progression rather than reversing it.
What to Expect

What to expect from cross-linking

The treatment is minimally invasive and performed in one session per eye.

1

Corneal topography

A detailed map of the corneal curvature confirms keratoconus and, compared against earlier maps, establishes that it is progressing.

2

Pachymetry

Corneal thickness is measured, since the cornea must be thick enough to undergo treatment safely.

3

Riboflavin drops

Vitamin B2 drops are applied to saturate the corneal tissue. This is the longest part of the appointment.

4

UVA light

Controlled ultraviolet light activates the riboflavin, forming new collagen cross-links that stiffen and stabilize the cornea.

5

Bandage lens and recovery

A protective contact lens is placed. Expect light sensitivity and discomfort for a few days while the surface heals.

6

Follow-up topography

Repeat maps over the following months confirm the cornea has stabilized. Vision correction is refined afterward.

OnlyProcedure that halts keratoconus
1990sDeveloped in Dresden, Germany
1 in 1,000Prevalence of keratoconus
B2 + UVARiboflavin and ultraviolet light
cross-linking FAQs

Frequently asked questions about cross-linking

What is corneal collagen cross-linking?

A minimally invasive procedure that uses vitamin B2 (riboflavin) drops and ultraviolet (UVA) light to increase the cornea’s collagen cross-links, helping it retain its firmness and shape. It was first developed in Dresden, Germany in the 1990s.

Does cross-linking cure keratoconus?

No. Collagen cross-linking is not a cure for keratoconus. It is the only procedure that can strengthen the cornea to slow or stop the progression of the disease.

Will my vision improve after cross-linking?

The goal is stability, not improvement. Some patients see modest flattening over time, but you should expect to still need glasses or specialty contact lenses afterward.

Who is a candidate?

Patients with progressive keratoconus whose corneas are thick enough to treat safely. Progression is established by comparing corneal topography over time, which is why early baseline maps matter.

How common is keratoconus?

It has been estimated to occur in about one out of every 1,000 people, and is generally first diagnosed in young people at puberty or in their late teens.

Does the procedure hurt?

The treatment itself is not painful. The surface of the eye is sore for several days afterward, with light sensitivity and watering, and a protective bandage contact lens is used while it heals.

How long does recovery take?

The corneal surface typically heals over several days. Vision fluctuates for weeks and continues settling for months, which is normal.

Can both eyes be treated?

Yes, though usually not on the same day. Your surgeon will plan the timing based on which eye is progressing and how you heal.

Keratoconus does not have to keep getting worse

If your prescription keeps changing and your corneal maps are shifting, cross-linking may be able to stop it. Book a cornea evaluation.